![](https://ml-eu.globenewswire.com/media/83be7368-4879-4e39-86a7-9e43c96b6011/small/logo-raphael-png.png)
Raphael Pharmaceutical Issues Letter to Shareholders
Highlights Company’s exclusive relationship with Rambam Health Care Campus, differentiated cannabinoid-based technology platform, promising lead product candidate for rheumatoid arthritis, recently commenced clinical study, broader pipeline opportunities, …